Gene: GUCY1B1
Official Full Name: guanylate cyclase 1 soluble subunit beta 1provided by HGNC
Gene Summary: This gene encodes the beta subunit of the soluble guanylate cyclase (sGC), which catalyzes the conversion of GTP (guanosine triphosphate) to cGMP (cyclic guanosine monophosphate). The encoded protein contains an HNOX domain, which serves as a receptor for ligands such as nitric oxide, oxygen and nitrovasodilator drugs. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07484 | GUCY1B1 Knockout cell line (HEK293) | Human | GUCY1B1 | 1:3~1:6 | Negative | Online Inquiry |
GUCY1B1 Gene Knockout Cell Lines are precision-engineered cellular models designed to facilitate the study of the GUCY1B1 gene's functions and its implications in various biological processes. This product offers researchers a robust platform for investigating the physiological roles of this gene, known for its critical involvement in nitric oxide signaling pathways, particularly in vascular and neuronal tissues.
The key function of GUCY1B1 knockout cell lines lies in their ability to lack the GUCY1B1 gene, thereby allowing for the in-depth analysis of cellular responses and signaling mechanisms without the confounding effects of this gene. By employing CRISPR-Cas9 technology for the gene knockout, these cell lines exhibit alterations in cyclic guanosine monophosphate (cGMP) signaling pathways, enabling researchers to explore therapeutic targets for conditions such as hypertension, heart failure, and neurodegenerative diseases.
The scientific importance of GUCY1B1 knockout cell lines extends to their application in drug discovery and development. Researchers can utilize these models to assess pharmacological responses, evaluate the efficacy of novel compounds, and study disease mechanisms linked to altered GUCY1B1 expression in both in vitro and in vivo studies.
Compared to other available cell lines, GUCY1B1 knockout models provide distinct advantages due to their specificity and precision. While traditional methods may yield varied results influenced by the non-targeted gene backgrounds, these knockout lines afford a controlled environment for clearer insights into gene function and its biological implications.
This product is invaluable for researchers and clinicians aiming to unravel the complexities of nitric oxide signaling, and its dysregulation in disease states. With the growing emphasis on targeted therapies in precision medicine, GUCY1B1 knockout cell lines represent a critical tool for advancing our understanding of cardiovascular and neuronal health.
Our company is committed to delivering high-quality biological products, and our expertise in genetic engineering and cell biology ensures that GUCY1B1 knockout cell lines meet the rigorous standards demanded by today's researchers, fostering innovative discoveries in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.